Sequoia Sciences is a pharmaceutical company discovering and developing new medicines for the treatment of bacterial infections and cancers. Our development programs consist of small molecules targeting bacterial infections and cancers, and also vaccines for the treatment and prevention of recurrent urinary tract infections. Sequoia is engaged in research and development programs and collaborations with laboratories, universities, clinical research sites, and private businesses. Our goal is to improve the quality of life for those individuals significantly affected by recurrent and chronic bacterial infections and cancers.
Recent Publications | See All
February 2014: Starks, C.M.; Williams, R.B.; Norman, V.L.; Rice, S.M.; O'Neil-Johnson, M.A.; Lawrence, J.A.; Eldridge, G.R. "Antibacterial Chromene and Chromane Stilbenoids from Hymenocardia acida." Phytochemistry, 2014, 98,216-222
August 2013: Williams, Russell; Norman, Vanessa; Goering, Matt; O'Neil-Johnson, Mark; Eldridge, Gary; Starks, Courtney "Acetylated Dammarane-type Bisdesmosides from Combretum inflatum." Journal of Natural Products, 2013, 76, 1592-1597
June 2012: Starks, C.M.; Williams, R.B.; Norman, V.L.; Lawrence, J.A.; O'Neil-Johnson, M.A.; Eldridge, G.R. "Phenylpropanoids from Phragmipedium calurum and their Antiproliferative Activity." Phytochemistry, 2012, 82, 172-175
June 2012: Williams, R.B.; Martin, S.M.; Hu, J.F.; Norman, V.L.; Goering, M.G.; Loss, S.; O'Neil-Johnson, M.A.; Eldridge, G.R.; Starks, C.M. "Cytotoxic and Antibacterial Beilschmiedic Acids from a Gabonese Species of Beilschmiedia." Journal of Natural Products, 2012, 75, 1319-1325